BackgroundRemission and recovery rates for people with first-episode psychosis (FEP)
remain uncertain. AimsTo assess pooled prevalence rates of remission and recovery in FEP …

How will we view schizophrenia in 2030? Schizophrenia today is a chronic, frequently
disabling mental disorder that affects about one per cent of the world's population. After a …

Importance The OPUS 20-year follow-up is the longest follow-up of a randomized clinical
trial testing early intervention services (EIS) among individuals with first-episode …

Introduction: Recovery from serious mental illness has historically not been considered a
likely or even possible outcome. However, a range of evidence suggests the courses of SMI …

Schizophrenia has historically been considered to be a deteriorating disease, a view
reinforced by recent MRI findings of progressive brain tissue loss over the early years of …

Objective: Early detection in first-episode psychosis confers advantages for negative,
cognitive, and depressive symptoms after 1, 2, and 5 years, but longitudinal effects are …

Objective Knowledge about course of illness can help clinicians to develop effective
interventions and improve treatment outcomes. The goal of this study was to construct …

A systematic review was conducted to assess the employment rate of people with
schizophrenia. Additionally, information from the selected studies concerning factors …

Negative symptoms, in particular motivational deficits, are reported as impediments to
functional recovery in patients with schizophrenia. This study examined the prevalence of …

BackgroundIn recent years there has been increasing interest in functional recovery in the
early phase of schizophrenia. Concurrently, new remission criteria have been proposed and …